POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, March 9, 2009   9:30 AM - 12:00 Noon
Hynes Convention Center, Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
21
Automatic Detection of Micrometastases in Lymph Nodes by Infrared Micro-Spectral Imaging
(111)
H Ashby-Richardson, NM Laver, SP Naber, BL Bird, M Diem - Tufts Medical Center, Boston, MA; Northeastern University, Boston, MA
Epithelial Cell Adhesion Molecule Is Overexpressed in Breast Cancer Metastases Compared to Matched Primary Cancers
(140)
A Cimino, M Halushka, P Illei, D Molavi, X Wu, S Sukumar, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Relationship between Molecular Phenotype of Invasive Breast Cancer and Expression of Androgen Receptor
(141)
K Cole, R Tamimi, R Hu, G Colditz, S Schnitt, L Collins - Beth Israel Deaconess Medical Center, Harvard Medical School; Harvard School of Public Health; and Brigham and Women's Hospital, Boston, MA; Washington Univ. School of Medicine, St. Louis, MO
Benign Breast Biopsies in Women That Later Developed Carcinoma: Distinctive Histologic Features and Stem Cell Marker Expression
(147)
C Cookingham, K Toy, CG Kleer - University of Michigan, Ann Arbor, MI
Pathologic Response and Microvascular Surface Area in Breast Cancer Treated with Neoadjuvant Chemotherapy
(148)
AD Corben, R Abi-Raad, R Boutrus, DC Sgroi, A Taghian, EF Brachtel - Massachusetts General Hospital, Boston, MA
Predictive Markers (ER, PR, HER2, HER2FISH) Pre- and Post-Neoadjuvant Chemotherapy in Primary Breast Carcinoma
(150)
MD Darrow, C Cohen, A Nassar - Emory University, Atlanta, GA; The Mayo Clinic, Rochester, MN
"Modified" Alcian Blue Enhances the Intraoperative Diagnosis of Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Study
(164)
C Fan, D Malik, S Kulkartni, N Daoud, D Tan, T Khoury - Roswell Park Cancer Institute, Buffalo, NY; MD Anderson, Houston, TX
Ductal Carcinoma In Situ in Women under Age of 35
(172)
J Gao, ME Sullivan, SA Khan, B Susnik - Northwestern University Feinberg School of Medicine, Chicago, IL
Microarray CGH Analysis Reveals Genetic Heterogeneity between Distinct Components of Metaplastic Breast Carcinomas
(175)
FC Geyer, D de Biase, B Weigelt, MBK Lambros, A Mackay, K Fenwick, N Tamber, A Ashworth, JS Reis-Filho - ICR, London, United Kingdom; Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley
Detailed FISH Analysis of HER2 2+ Immunohistochemistry Cases: Rarity of Cases with High Level HER2 Gene Amplification
(179)
DC Gingell, DJ Dabbs, U Surti, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Validation of Dako DuoCISH HER2 Gene Amplification Assay
(182)
NA Granger, CM Haynes, A Quinn, X Wang, P Tang, L McMahon, H Yaziji, D Hicks, LM Schiffhauer - University of Rochester, Rochester, NY; Vitro Molecular Laboratories, Miami, FL; SUNY Syracuse, Syracuse, NY; Stanford University, Stanford, CA
Can ER and CK5 Identify Atypical Epithelial Proliferations in Papillary Lesions of the Breast on Core Biopsy?
(184)
AN Grin, FP O'Malley, AM Mulligan - University of Toronto Mount Sinai Hospital; AND St. Michael's Hospital, Toronto, ON, Canada
Comparative Analysis of p53 Expression in Triple Negative Versus Non-Triple Negative Invasive Breast Cancers
(192)
JS Han, KH Molberg, V Sarode, AV Gavino, Y Peng - UT Southwestern, Dallas, TX
Positive HER2 Immunoreactivity in DCIS Is Associated with a Higher Incidence of Invasive Disease, Particularly in the Subsequent Resection in a Group of Patients without Radiographic Evidence of Invasion Disease
(194)
S Harada, R Roses, HL Niu, S Weinstern, H Nisenbaum, KR Fox, BJ Czerniecki, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
Utility of Frozen Section for Intra-Operative Evaluation of Sentinel Lymph Nodes in Breast Cancer
(224)
UR Kundu, KK Hunt, S Krishnamurthy - MD Anderson Cancer Center, Houston, TX
Metaplastic Sarcomatoid Carcinoma of the Breast: Poor Overall Survival Is Independent of the Amount of Sarcomatoid Component
(231)
TR Lester, KM Nayeemuddin, WG Davis, KK Hunt, MZ Gilcrease - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Breast Carcinoma and Lobule Development in Males: 5 Year Review at the Ottawa Hospital
(241)
M Marinescu, IT Ahmed, S Roberson - The Ottawa Hospital, The University of Ottawa, Ottawa, ON, Canada
Objective Assessment of Lymphatic and Blood Vascular Invasion in Breast Carcinoma: Findings from a Large Case Series with Long Term Follow up
(246)
RA Mohammed, SG Martin, AM Mahmmod, EC Paish, IO Ellis - School of Molecular Medical Sciences-University of Nottingham, Nottingham, United Kingdom; Faculty of Medicine-Assiut University, Assiut, Egypt
Y-Box-Binding Protein-1 Expression Is Associated with Suppressed E-Cadherin Levels and Poor Prognosis in Breast Cancer
(256)
T Ng, V Evdokimova, N Melnyk, P Sorensen - BC Cancer Research Centre and University of British Columbia, Vancouver, BC, Canada
Pleomorphic Carcinoma of the Breast: Is Severe Pleomorphism Associated with a Worse Clinical Outcome?
(257)
CV Nguyen, KK Hunt, KM Nayeemuddin, TR Lester, R Falcon-Escobedo, MZ Gilcrease - University of Texas M.D. Anderson Cancer Center, Houston, TX; and Medical School, Autonomous University of San Luis Potosi, San Luis Potosi, Mexico
Androgen Receptor Expression in Breast Cancer Molecular Classes: An Immunohistochemical Study of 190 Consecutive Cases
(259)
LA Niemeier, DJ Dabbs, JM Striebel, R Bhargava - University of Pittsburgh Medical Center, Pittsburgh, PA
Mucocele-Like Lesions Diagnosed by Core Needle Biopsy of the Breast: Correlation with Surgical Excision
(272)
DGK Phillips, CJ Sailey, J Warner, OB Ioffe - Univ of MD, Baltimore, MD
Breast Cancer Incidence: A Possible Relationship to Folic Acid Fortification?
(276)
P Reddy, M Hogarth, C-S Li, JW Miller, R Green -University of California, Davis, Sacramento, CA
Evaluation of the Predictive Ability of a CK5/p63/CK8/18 Antibody Cocktail in Stratifying Breast Papillary Lesions on Needle Biopsy: An Algorithmic Approach Works Best
(278)
ES Reisenbichler, AL Adams, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Columnar Cell Lesions Diagnosed by Core Needle Biopsy of the Breast: Correlation with Surgical Excision
(284)
CJ Sailey, DGK Phillips, J Warner, OB Ioffe - Univ of Maryland, Baltimore, MD
Tumor Proteomic Profiling Predicts the Resistance of Breast Cancer to Chemotherapy
(291)
D Shen, J He, DU Cheung, KF Faull, JP Whitelegge, RE Saxton, HR Chang - UCLA David Geffen School of Medicine and USC Keck School of Medicine, Los Angeles, CA
Isolated Tumor Cells and/or Micrometastasis in Breast Sentinel Lymph Nodes Can Be the Result of Innocuous Passive Dissemination
(293)
BB Shetuni, S Simpson, K Yearsley, Y Xiao, SH Barsky - The Ohio State University College of Medicine, Columbus, OH
Use of the Veridex GeneSearch BLN Assay in Clinical Practice To Evaluate Breast Sentinel Lymph Nodes
(295)
N Sidiropoulos, LJ Tafe, MC Schwab, EJ Rizzo, SN Schutz, SH Boyle, PP Seery, WA Wells, GJ Tsongalis - Dartmouth Medical School, Dartmouth Hitchcock Medical Center, and Norris Cotton Cancer Center, Lebanon, NH
Human Epididymis Protein 4 Expression Loss in Invasive Mammary Carcinoma Is Associated with Aggressive Disease and Adverse Clinical Outcome
(300)
EA Slodkowska, CE Sheehan, AB Boguniewicz, CB Sheehan, C Chen, JS Ross - Albany Medical College, Albany, NY
Indoleamine 2,3-Dioxygenase Expression in Invasive Breast Carcinoma Is Associated with Longer Relapse-Free Survival
(304)
MR Steciuk, JD Pfeifer, MA Watson, O Hameed - University of Alabama at Birmingham, Birmingham, AL; Washington University, St. Louis, MO
Bcl-2 Is Infrequently Upregulated in Metastatic Breast Carcinomas
(306)
AP Subhawong, DW Molavi, MK Halushka, H Nassar, R Vang, S Sukumar, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Comparison of Gene Expression Profiles of Areas of Micropapillary Differentiation of Invasive Breast Carcinomas with Focal MP features with Usual Ductal (No Special Type) Components
(318)
MJ Wagoner, G Paragh, Z Rakosy, M Ghayouri, G Acs - University of South Florida College of Medicine, Tampa, FL; Moffitt Cancer Center, Tampa, FL
Expression of Insulin-Like Growth Factor-I Receptor in Normal Breast Tissue and Breast Cancer Risk: Results from the Nurses' Health Study
(320)
Y Wang, J Connolly, R Hu, H Baer, G Colditz, S Schnitt, L Collins, R Tamimi - Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Harvard School of Public Health; and Harvard Medical School, Boston, MA; Washington University School of Medicine, St. Louis, MO
Estrogen/Progesterone Receptor and HER2 Expression Profiles in Breast Cancers with Isolated Bone Metastasis Are Different from Those in BCs with Metastasis to Other Sites
(321)
S Wei, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Does Nottingham Grade, MIB-1 Labeling Index Predict Recurrence Score of Oncotype Dx Assay?
(333)
Z Zhang, R Shamanna, U Raju, A Ormsby, D Chitale - Henry Ford Hospital, Detroit, MI